+1 915 229 3004 (U.S.) |
+44 7452 242832 (U.K.)

Table of Contents:
1. Executive summary
2. Market Introduction
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. Research Methodology
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Modality
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. Market Dynamics
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. Market Factor Analysis
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL Maternal Health MARKET, BY Pregnancy
6.1. Overview
6.2. Intrauterine
6.3. Ectopic
6.4. Tubal
6.5. Others
7. GLOBAL Maternal Health MARKET, BY Complication
7.1. Overview
7.2. Miscarriage
7.3. Premature Labor & Birth
7.4. Preeclampsia
7.5. Gestational Diabetes
7.6. Placenta Previa
7.7. Others
8. GLOBAL Maternal Health MARKET, BY Care
8.1. Overview
8.2. Prenatal Care
8.3. Postnatal Care
9. GLOBAL Maternal Health MARKET, BY Drug Class
9.1. Overview
9.2. Hormones
9.3. Nutritives
9.4. Analgesics
9.5. Anti-Infectives
9.6. Others
10. GLOBAL Maternal Health MARKET, by Region
10.1. Overview
10.2. North America
10.2.1. U.S.
10.2.2. Canada
10.3. Europe
10.3.1. Germany
10.3.2. France
10.3.3. U.K
10.3.4. Italy
10.3.5. Spain
10.3.6. Rest of Europe
10.4. Asia-Pacific
10.4.1. China
10.4.2. India
10.4.3. Japan
10.4.4. South Korea
10.4.5. Australia
10.4.6. Rest of Asia-Pacific
10.5. Rest of the World
10.5.1. Middle East
10.5.2. Africa
10.5.3. Latin America
11. Competitive Landscape
11.1. Overview
11.2. Competitive Analysis
11.3. Market Share Analysis
11.4. Major Growth Strategy in the Global Maternal Health Market,
11.5. Competitive Benchmarking
11.6. Leading Players in Terms of Number of Developments in the Global Maternal Health Market,
11.7. Key developments and Growth Strategies
11.7.1. New Pregnancy Launch/Complication Care
11.7.2. Merger & Acquisitions
11.7.3. Joint Ventures
11.8. Major Players Financial Matrix
11.8.1. Sales & Operating Income, 2022
11.8.2. Major Players R&D Expenditure. 2022
12. Company ProfileS
12.1. AGILE THERAPEUTICS
12.1.1. Company Overview
12.1.2. Financial Overview
12.1.3. Pregnancys Offered
12.1.4. Key Developments
12.1.5. SWOT Analysis
12.1.6. Key Strategies
12.2. Sanofi
12.2.1. Company Overview
12.2.2. Financial Overview
12.2.3. Pregnancys Offered
12.2.4. Key Developments
12.2.5. SWOT Analysis
12.2.6. Key Strategies
12.3. OKAMOTO INDUSTRIES
12.3.1. Company Overview
12.3.2. Financial Overview
12.3.3. Pregnancys Offered
12.3.4. Key Developments
12.3.5. SWOT Analysis
12.3.6. Key Strategies
12.4. Fuji Latex Co
12.4.1. Company Overview
12.4.2. Financial Overview
12.4.3. Pregnancys Offered
12.4.4. Key Developments
12.4.5. SWOT Analysis
12.4.6. Key Strategies
12.5. Reckitt Benckiser Group
12.5.1. Company Overview
12.5.2. Financial Overview
12.5.3. Pregnancys Offered
12.5.4. Key Developments
12.5.5. SWOT Analysis
12.5.6. Key Strategies
12.6. JOHNSON AND JOHNSON
12.6.1. Company Overview
12.6.2. Financial Overview
12.6.3. Pregnancys Offered
12.6.4. Key Developments
12.6.5. SWOT Analysis
12.6.6. Key Strategies
13. Appendix
13.1. References
13.2. Related Reports
LIST OF TABLES
TABLE 1 Global Maternal Health Market, Synopsis, 2018-2032
TABLE 2 Global Maternal Health Market, Estimates & Forecast, 2018-2032 (USD BILLION)
TABLE 3 GLOBAL Maternal Health MARKET, BY Pregnancy, 2018-2032 (USD BILLION)
TABLE 4 GLOBAL Maternal Health MARKET, BY COMPLICATION, 2018-2032 (USD BILLION)
TABLE 5 GLOBAL Maternal Health MARKET, BY CARE, 2018-2032 (USD BILLION)
TABLE 6 GLOBAL Maternal Health MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 7 North America Maternal Health MARKET, BY Pregnancy, 2018-2032 (USD BILLION)
TABLE 8 North America Maternal Health MARKET, BY COMPLICATION, 2018-2032 (USD BILLION)
TABLE 9 North America Maternal Health MARKET, BY CARE, 2018-2032 (USD BILLION)
TABLE 10 North America Maternal Health MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 11 North America Maternal Health MARKET, BY Country, 2018-2032 (USD BILLION)
TABLE 12 U.S. Maternal Health MARKET, BY Pregnancy, 2018-2032 (USD BILLION)
TABLE 13 U.S. Maternal Health MARKET, BY COMPLICATION, 2018-2032 (USD BILLION)
TABLE 14 U.S. Maternal Health MARKET, BY CARE, 2018-2032 (USD BILLION)
TABLE 15 U.S. Maternal Health MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 16 Canada Maternal Health MARKET, BY Pregnancy, 2018-2032 (USD BILLION)
TABLE 17 Canada Maternal Health MARKET, BY COMPLICATION, 2018-2032 (USD BILLION)
TABLE 18 Canada Maternal Health MARKET, BY CARE, 2018-2032 (USD BILLION)
TABLE 19 Canada Maternal Health MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 20 Europe Maternal Health MARKET, BY Pregnancy, 2018-2032 (USD BILLION)
TABLE 21 Europe Maternal Health MARKET, BY COMPLICATION, 2018-2032 (USD BILLION)
TABLE 22 Europe Maternal Health MARKET, BY CARE, 2018-2032 (USD BILLION)
TABLE 23 Europe Maternal Health MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 24 Europe Maternal Health MARKET, BY Country, 2018-2032 (USD BILLION)
TABLE 25 Germany Maternal Health MARKET, BY Pregnancy, 2018-2032 (USD BILLION)
TABLE 26 Germany Maternal Health MARKET, BY COMPLICATION, 2018-2032 (USD BILLION)
TABLE 27 Germany Maternal Health MARKET, BY CARE, 2018-2032 (USD BILLION)
TABLE 28 Germany Maternal Health MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 29 France Maternal Health MARKET, BY Pregnancy, 2018-2032 (USD BILLION)
TABLE 30 France Maternal Health MARKET, BY COMPLICATION, 2018-2032 (USD BILLION)
TABLE 31 France Maternal Health MARKET, BY CARE, 2018-2032 (USD BILLION)
TABLE 32 France Maternal Health MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 33 Italy Maternal Health MARKET, BY Pregnancy, 2018-2032 (USD BILLION)
TABLE 34 Italy Maternal Health MARKET, BY COMPLICATION, 2018-2032 (USD BILLION)
TABLE 35 Italy Maternal Health MARKET, BY CARE, 2018-2032 (USD BILLION)
TABLE 36 Italy Maternal Health MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 37 Spain Maternal Health MARKET, BY Pregnancy, 2018-2032 (USD BILLION)
TABLE 38 Spain Maternal Health MARKET, BY COMPLICATION, 2018-2032 (USD BILLION)
TABLE 39 Spain Maternal Health MARKET, BY CARE, 2018-2032 (USD BILLION)
TABLE 40 Spain Maternal Health MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 41 U.K Maternal Health MARKET, BY Pregnancy, 2018-2032 (USD BILLION)
TABLE 42 U.K Maternal Health MARKET, BY COMPLICATION, 2018-2032 (USD BILLION)
TABLE 43 U.K Maternal Health MARKET, BY CARE, 2018-2032 (USD BILLION)
TABLE 44 U.K Maternal Health MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 45 Rest of Europe Maternal Health MARKET, BY Pregnancy, 2018-2032 (USD BILLION)
TABLE 46 Rest of Europe Maternal Health MARKET, BY COMPLICATION, 2018-2032 (USD BILLION)
TABLE 47 Rest of Europe Maternal Health MARKET, BY CARE, 2018-2032 (USD BILLION)
TABLE 48 Rest of Europe Maternal Health MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 49 Asia Pacific Maternal Health MARKET, BY Pregnancy, 2018-2032 (USD BILLION)
TABLE 50 Asia Pacific Maternal Health MARKET, BY COMPLICATION, 2018-2032 (USD BILLION)
TABLE 51 Asia Pacific Maternal Health MARKET, BY CARE, 2018-2032 (USD BILLION)
TABLE 52 Asia Pacific Maternal Health MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 53 Asia Pacific Maternal Health MARKET, BY Country, 2018-2032 (USD BILLION)
TABLE 54 Japan Maternal Health MARKET, BY Pregnancy, 2018-2032 (USD BILLION)
TABLE 55 Japan Maternal Health MARKET, BY COMPLICATION, 2018-2032 (USD BILLION)
TABLE 56 Japan Maternal Health MARKET, BY CARE, 2018-2032 (USD BILLION)
TABLE 57 Japan Maternal Health MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 58 China Maternal Health MARKET, BY Pregnancy, 2018-2032 (USD BILLION)
TABLE 59 China Maternal Health MARKET, BY COMPLICATION, 2018-2032 (USD BILLION)
TABLE 60 China Maternal Health MARKET, BY CARE, 2018-2032 (USD BILLION)
TABLE 61 China Maternal Health MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 62 India Maternal Health MARKET, BY Pregnancy, 2018-2032 (USD BILLION)
TABLE 63 India Maternal Health MARKET, BY COMPLICATION, 2018-2032 (USD BILLION)
TABLE 64 India Maternal Health MARKET, BY CARE, 2018-2032 (USD BILLION)
TABLE 65 India Maternal Health MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 66 Australia Maternal Health MARKET, BY Pregnancy, 2018-2032 (USD BILLION)
TABLE 67 Australia Maternal Health MARKET, BY COMPLICATION, 2018-2032 (USD BILLION)
TABLE 68 Australia Maternal Health MARKET, BY CARE, 2018-2032 (USD BILLION)
TABLE 69 Australia Maternal Health MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 70 south korea Maternal Health MARKET, BY Pregnancy, 2018-2032 (USD BILLION)
TABLE 71 south korea Maternal Health MARKET, BY COMPLICATION, 2018-2032 (USD BILLION)
TABLE 72 south korea Maternal Health MARKET, BY CARE, 2018-2032 (USD BILLION)
TABLE 73 south korea Maternal Health MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 74 Rest of asia-pacific Maternal Health MARKET, BY Pregnancy, 2018-2032 (USD BILLION)
TABLE 75 Rest of asia-pacific Maternal Health MARKET, BY COMPLICATION, 2018-2032 (USD BILLION)
TABLE 76 Rest of asia-pacific Maternal Health MARKET, BY CARE, 2018-2032 (USD BILLION)
TABLE 77 Rest of asia-pacific Maternal Health MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 78 Rest of WOrld Maternal Health MARKET, BY Pregnancy, 2018-2032 (USD BILLION)
TABLE 79 Rest of WOrld Maternal Health MARKET, BY COMPLICATION, 2018-2032 (USD BILLION)
TABLE 80 Rest of WOrld Maternal Health MARKET, BY CARE, 2018-2032 (USD BILLION)
TABLE 81 Rest of WOrld Maternal Health MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 82 Rest of WOrld Maternal Health MARKET, BY Country, 2018-2032 (USD BILLION)
TABLE 83 Middle east Maternal Health MARKET, BY Pregnancy, 2018-2032 (USD BILLION)
TABLE 84 Middle east Maternal Health MARKET, BY COMPLICATION, 2018-2032 (USD BILLION)
TABLE 85 Middle east Maternal Health MARKET, BY CARE, 2018-2032 (USD BILLION)
TABLE 86 Middle east Maternal Health MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 87 Africa Maternal Health MARKET, BY Pregnancy, 2018-2032 (USD BILLION)
TABLE 88 Africa Maternal Health MARKET, BY COMPLICATION, 2018-2032 (USD BILLION)
TABLE 89 Africa Maternal Health MARKET, BY CARE, 2018-2032 (USD BILLION)
TABLE 90 Africa Maternal Health MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
TABLE 91 Latin america Maternal Health MARKET, BY Pregnancy, 2018-2032 (USD BILLION)
TABLE 92 Latin america Maternal Health MARKET, BY COMPLICATION, 2018-2032 (USD BILLION)
TABLE 93 Latin america Maternal Health MARKET, BY CARE, 2018-2032 (USD BILLION)
TABLE 94 Latin america Maternal Health MARKET, BY DRUG CLASS, 2018-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 Research Process
FIGURE 2 Market Structure for the Global Maternal Health Market
FIGURE 3 Market Dynamics for the Global Maternal Health Market
FIGURE 4 Global Maternal Health Market, Share (%), BY Pregnancy, 2022
FIGURE 5 Global Maternal Health Market, Share (%), BY COMPLICATION, 2022
FIGURE 6 Global Maternal Health Market, Share (%), BY CARE, 2022
FIGURE 7 Global Maternal Health Market, Share (%), BY DRUG CLASS, 2022
FIGURE 8 Global Maternal Health Market, Share (%), by Region, 2022
FIGURE 9 north AMERICA: Maternal Health MARKET, SHARE (%), BY REGION, 2022
FIGURE 10 Europe: Maternal Health MARKET, SHARE (%), BY REGION, 2022
FIGURE 11 Asia-Pacific: Maternal Health MARKET, SHARE (%), BY REGION, 2022
FIGURE 12 Rest of the world: Maternal Health MARKET, SHARE (%), BY REGION, 2022
FIGURE 13 Global Maternal Health Market: Company Share Analysis, 2022 (%)
FIGURE 14 AGILE THERAPEUTICS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 15 AGILE THERAPEUTICS: SWOT ANALYSIS
FIGURE 16 Sanofi: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 17 Sanofi: SWOT ANALYSIS
FIGURE 18 OKAMOTO INDUSTRIES: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 OKAMOTO INDUSTRIES: SWOT ANALYSIS
FIGURE 20 Fuji Latex Co: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 Fuji Latex Co: SWOT ANALYSIS
FIGURE 22 Reckitt Benckiser Group.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 Reckitt Benckiser Group.: SWOT ANALYSIS
FIGURE 24 JOHNSON AND JOHNSON: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 JOHNSON AND JOHNSON: SWOT ANALYSIS
Report Code :
RL6546
Published on :
Aug 2023
Request a Free Sample Report